Opioid Manufacturer Endo Health Solutions Inc. Ordered to Pay $1.536B In Criminal Fines and Forfeiture for Distributing Misbranded Opioid Medication.
Předmět: | |
---|---|
Zdroj: | Pharma Business Week; 5/21/2024, p1422-1422, 1p |
Abstrakt: | Endo Health Solutions Inc. has been ordered to pay $1.536 billion in criminal fines and forfeiture for distributing misbranded opioid medication. The company pleaded guilty to introducing misbranded drugs into interstate commerce and admitted that its sales representatives marketed the drug Opana ER with false claims of abuse deterrence and tamper resistance. The company's corporate affiliates have emerged from bankruptcy and will fund voluntary trusts to settle opioid-related claims. The sentencing reflects the commitment of the Department of Justice to hold companies accountable for their role in the opioid crisis. [Extracted from the article] |
Databáze: | Complementary Index |
Externí odkaz: |